Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy

Cuadrado, AntonioAntonioCuadradoKügler, SebastianSebastianKüglerLastres-Becker, IsabelIsabelLastres-Becker2020-12-102020-12-1020182213-2317https://resolver.sub.uni-goettingen.de/purl?gro-2/72896enPharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathyjournal_article10.1016/j.redox.2017.10.010